PedAM
Pediatric Disease Annotations & Medicines
| Disease | primary myelofibrosis |
| Symptom | C0026986|myelodysplastic syndrome |
| Sentences | 9 |
| PubMedID- 24186132 | In this study, we assessed the prognostic impact of bone marrow fibrosis in patients with primary myelodysplastic syndromes under the recently revised new risk stratification systems: the new comprehensive cytogenetic scoring system and the revised international prognostic scoring system. |
| PubMedID- 20971823 | Background: bone marrow fibrosis in patients with myelodysplastic syndrome is associated with a poor outcome, but whether the outcome after allogeneic stem cell transplantation is related to the degree of bone marrow fibrosis is unknown. |
| PubMedID- 22937321 | A diagnosis of myelodysplastic syndrome (mds) with myelofibrosis was rendered. |
| PubMedID- 23660629 | The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes. |
| PubMedID- 24809010 | Hematologic improvements in a myelodysplastic syndromes with myelofibrosis (mds-f) patient treated with azacitidine. |
| PubMedID- 26171043 | Primary myelodysplastic syndrome (mds) with myelofibrosis is a rare hematological disorder that should be classified as a distinct subgroup of mds. |
| PubMedID- 22781796 | Analysis of clinical features and prognosis of primary myelodysplastic syndromes with myelofibrosis patients. |
| PubMedID- 23882429 | An exceptional case of myelodysplastic syndrome with myelofibrosis following combination chemotherapy for squamous cell lung cancer. |
| PubMedID- 21282718 | myelodysplastic syndromes with bone marrow fibrosis. |
Page: 1